Unique features of PTCH1 mutation spectrum in Chinese sporadic basal cell carcinoma

被引:9
|
作者
Huang, Y. S. [1 ,2 ,3 ]
Bu, D. F. [4 ]
Li, X. Y. [5 ]
Ma, Z. H. [1 ]
Yang, Y. [1 ]
Lin, Z. M. [1 ]
Lu, F. M. [6 ]
Tu, P. [1 ]
Li, H. [1 ]
机构
[1] Peking Univ, Hosp 1, Dept Dermatol & Venereol, Beijing 100871, Peoples R China
[2] Univ British Columbia, Mol Med Lab, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Chieng Genom Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada
[4] Peking Univ, Hosp 1, Cent Lab, Beijing 100871, Peoples R China
[5] Peking Univ, Hosp 1, Stat Off, Beijing 100871, Peoples R China
[6] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China
基金
高等学校博士学科点专项科研基金;
关键词
NONMELANOMA SKIN-CANCER; SONIC HEDGEHOG; PATCHED GENE; P53; MELANOMA; RECEPTOR; PATHWAY; TRENDS;
D O I
10.1111/j.1468-3083.2012.04453.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Alterations of the PTCH1 gene have been found to contribute to both familial and sporadic basal cell carcinoma (BCC), especially in Caucasian patients. Furthermore, the majority of PTCH1 gene mutations in sporadic BCCs in Caucasian patients carry ultraviolet (UV) signatures, suggesting the key role of UV light in BCC development. However, sporadic BCC in non-Caucasian population has a lower incidence, and the pathogenesis remains largely unknown. To date, there has been no mutation analysis on PTCH1 gene in Chinese patients with sporadic BCCs. Objective To investigate genetic alterations of the PTCH1 gene in Chinese sporadic BCCs. Methods Direct sequencing was used to screen for mutations in PTCH1 in 31 microdissected samples in Chinese sporadic BCCs. In addition, single nucleotide polymorphisms (SNPs) were studied for loss of heterozygosity (LOH). Results Nineteen PTCH1 mutations in 17 of the 31 BCCs (54.8%) were identified. SNP analysis revealed LOH of PTCH1 in 10 of 23 BCCs (43.5%). Interestingly, the majority of mutations identified (63.2%) were insertion/deletion, which was different from the results in Caucasian cases whose mutations are predominantly point mutations. Only two (10.5%) of the remaining seven mutations were UV-specific C --> T transition or tandem CC --> TT transitions. All mutations occurred evenly throughout the entire PTCH1 protein domain without a hot-spot detected. Conclusion Mutations and LOH in PTCH1 were also highly prevalent in Chinese sporadic BCCs. However, UV light plays a less role in causing these mutations, suggesting other potential mechanisms in the development of sporadic BCC in Chinese patients.
引用
收藏
页码:235 / 241
页数:7
相关论文
共 50 条
  • [31] Novel PTCH1 mutations in Japanese familial nevoid basal cell carcinoma syndrome
    Nakase, Yoji
    Hamada, Atsuko
    Kitamura, Naoya
    Hata, Tsuyoshi
    Toratani, Shigeaki
    Yamamoto, Tetsuya
    Okamoto, Tetsuji
    HUMAN GENOME VARIATION, 2020, 7 (01)
  • [32] Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene
    Chise Kato
    Kentaro Fujii
    Yuto Arai
    Hiromi Hatsuse
    Kazuaki Nagao
    Yoshinaga Takayama
    Kouzou Kameyama
    Katsunori Fujii
    Toshiyuki Miyashita
    Familial Cancer, 2017, 16 : 131 - 138
  • [33] Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation
    Kijima, Chihiro
    Miyashita, Toshiyuki
    Suzuki, Maiko
    Oka, Hidehiro
    Fujii, Kiyotaka
    FAMILIAL CANCER, 2012, 11 (04) : 565 - 570
  • [34] Novel mutation in PTCH1 gene in a patient with basal cell nevus syndrome and uterus bicornis
    Miyashiro, Denis
    Torezan, Luis Antonio
    Grinblat, Beni Moreinas
    Neto, Cyro Festa
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (04) : 487 - 489
  • [35] Examining dual loss of hedgehog receptors ptch1 and ptch2 in mouse models of basal cell carcinoma
    Peterson, S.
    Wong, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S17 - S17
  • [36] Metastatic basal cell carcinoma with a novel truncation mutation in PTCH1 successfully treated with combination chemotherapy containing cisplatin and doxorubicin
    Watanabe, Soichiro
    Iwata, Yohei
    Sugiura, Kazumitsu
    JOURNAL OF DERMATOLOGY, 2021, 48 (03): : E142 - E143
  • [37] Nevoid Basal Cell Carcinoma Syndrome: PTCH1 Mutation Profile and Expression of Genes Involved in the Hedgehog Pathway in Argentinian Patients
    Florencia Martinez, Maria
    Vanesa Romano, Maria
    Pedro Martinez, Alfredo
    Gonzalez, Abel
    Muchnik, Carolina
    Miguel Stengel, Fernando
    Daniel Mazzuoccolo, Luis
    Javier Azurmendi, Pablo
    CELLS, 2019, 8 (02)
  • [38] A novel germ-line mutation of PTCH1 gene in a Japanese family of nevoid basal cell carcinoma syndrome:: Are the palmoplantar pits associated with true basal cell carcinoma?
    Otsubo, Sawa
    Honma, Masaru
    Asano, Kazuhiro
    Takahashi, Hidetoshi
    Iizuka, Hajime
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2008, 51 (02) : 144 - 146
  • [39] Mosaicism for a variant in PTCH1 causing Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome)
    Sheyanth, Inger Norlyk
    Sommerlund, Mette
    Vinter, Hanne
    Assenholt, Jannie
    Gjorup, Hans
    Sunde, Lone
    Lundsgaard, Malene
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 290 - 290
  • [40] Evidence that superficial basal cell carcinoma is monoclonal from analysis of the Ptch1 gene locus
    Saldanha, G
    Shaw, JA
    Fletcher, A
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (05) : 931 - 935